ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Zafgen Inc

Zafgen Inc (ZFGN)

0.99
0.00
(0.00%)
Closed July 24 4:00PM
0.00
0.00
(0.00%)

Zafgen Inc Financial Summary

The current ZFGN market cap is 43.47M. The company's latest EPS is USD -0.8415 and P/E is -1.18.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -10.44M-7.64M-9.62M-10.34M-14.16M
Net Income -9.43M-6.53M-8.37M-9.06M-12.99M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -45.65M-42.8M-50.47M-36.53M-41.76M
Net Income -45.41M-42.48M-50.64M-35.36M-36.95M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 126.41M118.91M111.72M103.95M95.94M
Total Liabilities 15.5M12.67M11.79M11.24M14.22M
Total Equity 110.9M106.24M99.93M92.71M81.72M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 80.73M104.69M78.67M126.41M95.94M
Total Liabilities 27.11M14.99M14.25M15.5M14.22M
Total Equity 53.62M89.69M64.41M110.9M81.72M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -27.57M-7.55M-14.92M-24.12M-33.46M
Investing -90.96M92.25M82.41M35.98M33.35M
Financing 75.26M N/A N/A 30k30k
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -40.78M-42.2M-42.11M-27.57M-33.46M
Investing 25.26M17.09M24.17M-90.96M33.35M
Financing -5.26M93.59M19.89M75.26M30k
Market Cap 43.47M
Price to Earnings Ratio -1.18
Price to Sales Ratio 0
Price to Cash Ratio 1.63
Price to Book Ratio 0.53
Dividend Yield -

Share Statistics

Shares Outstanding 43.91M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (1%)

Company Info

Company Name Zafgen Inc
Address corporation trust center
wilmington, delaware 19801
Website https://larimartx.com
Industry pharmaceutical preparations (2834)